Paper Details

  1. Home
  2. Paper Details

Hysteroscopic myomectomy outcomes after 3-month treatment with either Ulipristal Acetate or GnRH analogues: a retrospective comparative study.

Author: AmateVicente Payá, CarrascosaAntonio Abad, DelgadoVerónica Serrano de la Cruz, SanchoJavier Monleón, SoterasMarta Gurrea, ValeroMaria José Nuñez

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Ulipristal acetate (UPA) is a safe and effective alternative to GnRH analogues for pre-treatment before hysteroscopic myomectomy.
Paper Details　
Original Abstract of the Article :
Ulipristal Acetate (UPA) modifies the endometrium, as well as fibroids, and therefore it might make hysteroscopic surgery more difficult. To confirm that pre-treatment with UPA is as safe and effective an option as pre-treatment with GnRH analogues, considered the gold standard. We present the first...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ejogrb.2016.01.014

データ提供：米国国立医学図書館（NLM）

A Comparative Study of Pre-Treatment Options for Hysteroscopic Myomectomy

This study delves into the world of gynecological surgery, specifically focusing on the effectiveness of pre-treatment options for hysteroscopic myomectomy. It's like choosing the right camel for a journey across the vast desert: Do you choose a camel that is already conditioned (GnRH analogues) or one that needs some training (Ulipristal Acetate)? The study aims to compare the safety and effectiveness of these two pre-treatment options for hysteroscopic myomectomy. This study is a fascinating example of how medical advancements are changing the landscape of gynecological surgery.

Ulipristal Acetate Shows Promising Results for Pre-Treatment

The study found that pre-treatment with Ulipristal Acetate (UPA) was just as safe and effective as pre-treatment with GnRH analogues. In fact, the surgeons subjectively found that UPA treatment was associated with an easier resection. This finding is particularly important because UPA has fewer side effects than GnRH analogues. It's like finding a camel that's already strong and ready to carry a heavy load, rather than having to spend time training it for the journey.

A New Frontier in Gynecological Care

This study highlights the importance of exploring new and innovative pre-treatment options for gynecological surgery. The potential of Ulipristal Acetate opens a new frontier in gynecological care, offering a safe and effective alternative to traditional treatments. It's a shining example of how medical research is constantly evolving and seeking better solutions for patient care.

Dr.Camel's Conclusion

This study is a testament to the importance of ongoing research in gynecological surgery. The results suggest that Ulipristal Acetate is a viable and promising option for pre-treatment before hysteroscopic myomectomy. It's like having a new map for navigating the desert of gynecological surgery, offering a safer and smoother journey for patients.

Date :
  1. Date Completed 2016-12-20
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

26871272

DOI: Digital Object Identifier

10.1016/j.ejogrb.2016.01.014

Related Literature

Article Analysis
・Side Effects of ulipristal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.